Markets:

Overview

News

Currencies

International

Treasuries

Inari Medical, Inc. - Common Stock (NQ:NARI)

79.97 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance

April 15, 2026

As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9...

Via MarketMinute

Topics Economy

Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A

April 15, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately...

Via MarketMinute

Topics Economy

Demystifying Inari Medical: Insights From 6 Analyst Reviews ↗

December 17, 2024

Via Benzinga

Key Takeaways From Inari Medical Analyst Ratings ↗

October 29, 2024

Via Benzinga

Inari Medical's Earnings: A Preview ↗

October 25, 2024

Via Benzinga

Breaking Down Inari Medical: 9 Analysts Share Their Views ↗

October 09, 2024

Via Benzinga

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The...

Via MarketMinute

Topics Artificial Intelligence

The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A

January 14, 2026

As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial...

Via MarketMinute

Topics Artificial Intelligence

If You Could Only Hold 3 Investments for Life, Consider These

March 10, 2025

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

Via MarketBeat

Topics ETFs Economy Retirement

Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts ↗

September 17, 2024

Via Benzinga

Breaking Down Inari Medical: 7 Analysts Share Their Views ↗

August 26, 2024

Via Benzinga

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗

January 12, 2025

These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 07, 2025

Via Benzinga

UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

January 07, 2025

Via Benzinga

Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position ↗

January 07, 2025

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.

Via Benzinga

Deep Dive Into Inari Medical Stock: Analyst Perspectives (5 Ratings) ↗

July 16, 2024

Via Benzinga

What 8 Analyst Ratings Have To Say About Inari Medical ↗

April 12, 2024

Via Benzinga

Forecasting The Future: 7 Analyst Projections For Inari Medical ↗

March 22, 2024

Via Benzinga

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket ↗

January 07, 2025

Via Benzinga

Inari Medical Catapults 30% On Rumored Stryker Takeover ↗

January 06, 2025

Inari is best-known for its series of catheter-like devices that remove blood clots.

Via Investor's Business Daily

Inari Medical Stock Gets RS Rating Upgrade ↗

December 11, 2024

On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

Via Investor's Business Daily

Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday ↗

October 29, 2024

Via Benzinga

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious ↗

August 26, 2024

The FDA labels Inari Medical's ClotTriever catheter recall as the most serious, citing risks like device entrapment and pulmonary emboli, linked to injuries and deaths.

Via Benzinga

7 Leading MedTech Stocks for Next-Gen Health Solutions ↗

July 31, 2024

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.

Via InvestorPlace

NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q2 2024 ↗

July 30, 2024

NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗

May 01, 2024

Via Benzinga

Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 01, 2024

Via Benzinga

Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

May 01, 2024

Via Benzinga

NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024 ↗

April 30, 2024

NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Market Cap Game Show: Andy Cross vs. Bill Mann ↗

March 30, 2024

Join the "Rule Breaker Investing" fun.

Via The Motley Fool

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.